Altre lingue TTY Biopharm Company Limited

Azioni

4105

TW0004105002

Prezzo di chiusura Taipei Exchange Altri mercati azionari 00:00:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
76,6 ^TWD	+0,13%		+0,79%	-4,73%

14/03	TTY Biopharm Company Limited riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI
30/01	TTY Biopharm Company Limited nomina Peng,Cheng-Yi come Responsabile della Ricerca e dello Sviluppo, a partire dal 01 febbraio 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

TTY Biopharm Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
TTY Biopharm Company Limited Announces Change of CFO and Financial Officer	08/03
TTY Biopharm Company Limited Proposes Cash Dividend for the Year Ended December 31, 2023, Payable on April 26, 2024	08/03
TTY Biopharm Company Limited Appoints Peng,Cheng-Yi as Research and Development Officer, Effective February 01, 2024	30/01
TTY Biopharm Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03/11
TTY Biopharm Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23
TTY Biopharm Company Limited Receives Milestone Payment from German Pharmaceutical Company for Co-Development of Liposome Product-Pegylipo in Europe	09/08/23
TTY Biopharm Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	05/05/23
TTY Biopharm Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	14/03/23
TTY Biopharm Company Limited Proposes Dividend Distribution for the Year Ended December 31, 2022, Payable on May 5, 2023	14/03/23
DelveInsight Estimates a Diverse Kaposi Sarcoma Pipeline Comprising 5+ Companies Working in the Domain	03/03/23
Aurobindo Pharma Arm Gets US FDA Nod for Amphotericin B Liposome	18/11/22
TTY Biopharm Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	04/11/22
TTY Biopharm Company Limited Announces Internal Audit Officer Changes, Effective November 7, 2022	04/11/22
TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in July 2022	11/08/22
TTY Biopharm Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	06/08/22
TTY Biopharm : Announcement of the consolidated financial report for the second quarter of year 2022	05/08/22
TTY Biopharm : To clarify report of China Times, Commercial Times and Economic Daily News on Aug 02, 2022	02/08/22
TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in June 2022	11/07/22
TTY Biopharm : Announcement of the record date of cash dividend.	01/07/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue TTY Biopharm Company Limited

Azioni

4105

TW0004105002

Altre lingue

Filtri